JPRN-jRCTc030190256招募中1 期
Multicenter clinical study of peptide-loaded dendritic cells in patients with malignant tumors.
Goto Shigenori0 个研究点目标入组 6,000 人开始时间: 2010年3月16日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 6,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •(1)Diagnostic imaging or Pathological diagnosis of malignant tumor.
- •(2)Informed consent has been obtained.
排除标准
- •(1)HIV Ab positive.
- •(2)T cell- or NK cell-originated leukemia and/or lymphoma.(LAK therapy)
- •(3)Patients who have previously treated allogenic transplantation.
- •(4)Responsible doctors judged the patient inappropriate for the clinical study.
研究者
相似试验
已完成
2 期
Multicenter clinical trial of Percutaneous Peptide Immunization for malignant melanoma patientsmalignant melanomaJPRN-UMIN000005706Hamamatsu University School of Medicine60
已完成
不适用
Clinical safety of peptide pulsed dendritic cell vaccine after radiofrequency ablation for hepatocellular carcinomaHepatocellular carcinomaJPRN-UMIN000020811Kanazawa University10
进行中（未招募）
1 期
Multicenter clinical study of immune-cell therapy in patients with malignant tumors.malignant tumorJPRN-jRCTc030190257Goto Shigenori6,000
尚未招募
不适用
The clinical study of the effect of peptide ingestion in addition to strength training on the muscle strength of middle-aged and elderly people.sarcopeniaJPRN-UMIN000018587Matsumoto University240
已完成
2 期
A phase II clinical trial of personalized peptide vaccination in combination with metformin for castration-resistant prostate cancer (CRPC)Castration-resistant prostate cancerJPRN-UMIN000019879Cancer Vaccine Center, Kurume University School of medicine35